In Response-Reference-Cited by-同舟云学术

In Response

Published:2024-02-15 Issue: Volume: Page:
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:

Author:

Peska Emil¹,Balki Mrinalini²,Pfeifer Wesla¹,Maxwell Cynthia³,Ye Xiang Y.⁴,Downey Kristi¹,Carvalho Jose C. A.⁵

Affiliation:

1. Department of Anesthesiology and Pain Medicine Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada

2. Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Department of Physiology University of Toronto Toronto, Ontario, Canada Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital Toronto, Ontario, Canada

3. Department of Obstetrics and Gynecology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada

4. Department of Biostatistics Princess Margaret Cancer Centre University Health Network Toronto, Ontario, Canada

5. Departments of Anesthesiology and Pain Medicine and Obstetrics and Gynecology Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Caveats for interpreting the results of up-down dose-finding studies for prophylactic oxytocin at caesarean delivery.;Bamber;Anesth Analg,2023

2. Oxytocin at elective cesarean delivery: a dose-finding study in pregnant people with twin pregnancy.;Peska;Anesth Analg,2022

3. International consensus statement on the use of uterotonic agents during caesarean section.;Heesen;Anaesthesia,2019

4. Minimum effective bolus dose of oxytocin during elective caesarean delivery.;Butwick;Br J Anaesth,2010

5. Oxytocin requirements at elective cesarean delivery: a dose-finding study.;Carvalho;Obstet Gynecol,2004